HD-OPM Archive
Topics › Brain health & dementia

PREVENT-E4: 2 g/day DHA did not slow cognitive decline in 365 at-risk older adults

Louis Nervegna · Jun 19, 2026 · ♥ 11 reactions · 10 comments · original Facebook post
Brain health & dementiaSupplements & vitaminsFats & oils (saturated fat, seed oils, omega-6, olive oil)
AI summary & key facts

Louis reports the PREVENT-E4 randomized trial found no cognitive or hippocampal-volume difference between DHA and placebo over two years, though it showed 2 g DHA reached spinal fluid equally in APOE4 carriers and non-carriers. The trial was small and designed mainly to test brain penetration.

High dose DHA (2g) from fish oil does not appear to slow cognitive decline in healthy older adults at high risk for Alzheimer’s, over a 2 year period.

These disappointing results were recently reported from the PREVENT-E4 randomized trial.

Over a 2 year period, there was no detectable difference in cognitive function between the DHA and placebo groups. Nor was there any detectable difference in brain volume of the hippocampus, as measured by MRI.

This was a fairly small trial, with only 365 participants. It was designed primarily to test how well high doses of DHA enter the brain.

About half the participants in the study were APOE4 carriers.

One silver lining of the study is that it has disproved the hypothesis that high dose DHA (2g) does not cross the blood brain barrier (BBB) well in APOE4 carriers.

On average, there was no difference in DHA levels in spinal fluid based on APOE4 status. The APOE4 carriers had levels just as high as non-carriers, meaning that the high 2g DHA dose crossed the BBB just as well in both groups.

Quoted:

Researchers recruited 365 adults, ages 55 to 80 who rarely ate fish, which is rich in omega-3s, and who study authors considered at risk for Alzheimer’s. About half (47%) carried an APOE4 gene, the strongest genetic risk factor for late-onset Alzheimer’s. Participants were randomly chosen to receive either daily fish oil supplements or a placebo. The supplements contained 2,000 mg of docosahexaenoic acid (DHA), a key omega-3 involved in brain function.

Researchers were first interested to learn whether the omega-3 in the supplement was able to reach the brain.

They measured DHA levels in cerebrospinal fluid, which surrounds the brain, and found an average 17% increase of DHA levels in patients’ brains after six months, confirming the omega-3 reached its intended target.

Next, researchers tested participants’ memory and cognitive abilities at the beginning of the study and again two years later. Study participants who took DHA supplements did no better on the tests than those who took a placebo. Brain scans also showed that supplements did not prevent shrinkage of the hippocampus, a brain region important for memory that is often used as a marker of brain aging and Alzheimer’s risk.

My notes:

The study was primarily designed to test DHA delivery to the brain (via CSF analysis), not to prove or disprove cognitive prevention. Because it lasted only 2 years and was not fully powered as a large-scale clinical trial for cognitive outcomes, the findings on cognition and hippocampal volume should really be considered as exploratory.

The researchers did observe that within the DHA-treated group, those APOE4 carriers who saw the greatest increase in DHA to Arachidonic Acid (DHA/AA) ratios in CSF showed better performance on certain cognitive measures. This suggests that while the standardized dose may not have provided a blanket benefit, there may still be a relationship between brain DHA levels and cognitive function in APOE4 carriers that requires further study.

#dhaHD #fishoilHD #omega3HD #prevente4HD #alzheimersHD #dementiaHD #apoe4HD #hippocampusHD #arachadonicacidHD

Fish oil supplements may not prevent Alzheimer’s-related declineFish oil supplements may not prevent Alzheimer’s-related declineLOS ANGELES — Americans spend more than $1 billion annually on fish oil supplements, in part due to purported cognitive benefits from the omega-3 fatty acids they contain, essential nutrients that help form brain cell connections needed for cognition. However, a new Keck Medicine of USC study published today in eBioMedicine suggests that incr...news.keckmedicine.org

Research cited

← newer: Stanford Medicine fiber facts: most people fall short of recolder: Some with high LDL avoid plaque, but heart disease is multif →